Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review

Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e420-e427. doi: 10.1016/j.clml.2023.08.008. Epub 2023 Aug 13.

Abstract

We performed a systematic review of the literature investigating the demographic and insurance-related factors linked to disparities in multiple myeloma (MM) care patterns in the United States from 2003 to 2021. Forty-six observational studies were included. Disparities in MM care patterns were reported based on patient race in 76% of studies (34 out of 45 that captured race as a study variable), ethnicity in 60% (12 out of 20), insurance in 77% (17 out of 22), and distance from treating facility, urbanicity, or geographic region in 62% (13 out of 21). A smaller proportion of studies identified disparities in MM care patterns based on other socioeconomic characteristics, with 36% (9 out of 25) identifying disparities based on income estimate or employment status and 43% (6 out of 14) based on language barrier or education-related factors. Sociodemographic characteristics are frequently associated with disparities in care for individuals diagnosed with MM. There is a need for further research regarding modifiable determinants to accessing care such as insurance plan design, patient out-of-pocket costs, preauthorization criteria, as well as social determinants of health. This information can be used to develop actionable strategies for reducing MM health disparities and enhancing timely and high-quality MM care.

Keywords: Health equity; Health insurance; Hematologic malignancies; Race; Social determinants of health.

Publication types

  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Ethnicity
  • Health Expenditures
  • Healthcare Disparities
  • Humans
  • Income
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / epidemiology
  • Multiple Myeloma* / therapy
  • Socioeconomic Factors
  • United States / epidemiology